
JZP-361
CAS No. 1680193-80-9
JZP-361( —— )
Catalog No. M34301 CAS No. 1680193-80-9
JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 36 | Get Quote |
![]() ![]() |
10MG | 56 | Get Quote |
![]() ![]() |
25MG | 109 | Get Quote |
![]() ![]() |
50MG | 181 | Get Quote |
![]() ![]() |
100MG | 266 | Get Quote |
![]() ![]() |
200MG | 377 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameJZP-361
-
NoteResearch use only, not for human use.
-
Brief DescriptionJZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6.
-
DescriptionJZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research.
-
In VitroJZP-361 has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50 = 7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50 = 1.79 μM).JZP-361 retains H1 antagonistic affinity (pA2 = 6.81) but did not show cannabinoid receptor activity, when tested at concentrations ≤10 μM.JZP-361 displays favorable interactions within the active site of hMAGL including the important hydrogen-bonding of the carbonyl oxygen to the oxyanion hole.
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetLipase
-
RecptorLipase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1680193-80-9
-
Formula Weight405.88
-
Molecular FormulaC22H20ClN5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (307.97 mM; Ultrasonic (<60°C)
-
SMILESClc1ccc2c(CCc3cccnc3C2=C2CCN(CC2)C(=O)n2cncn2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jayendra Z Patel,?et al. Loratadine analogues as MAGL inhibitors. Bioorg Med Chem Lett.?2015 Apr 1;25(7):1436-42.?
molnova catalog



related products
-
JW 642
JW 642 is an effective inhibitor of monoacylglycerol lipase (MAGL)
-
Lalistat 2
Lalistat 2 is a selective inhibitor of lysosomal acid lipase with IC50 of 152 nM and exhibits no inhibition of human pancreatic lipase or bovine milk lipoprotein lipase (up to 10 μM).
-
JNJ-42226314
JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.